Rapid resistance profiling of SARS-CoV-2 protease inhibitors https://www.biorxiv.org/content/10.1101/2023.02.25.530000v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.